Dextrosone

Quick links to important sections

Dextrosone

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dextrosone

Quick Facts

Property Description
Active Ingredients Betamethasone Dipropionate, Dexchlorpheniramine
Form Oral Tablet
Pharmacological Class Glucocorticoid (Corticosteroid) and First-Generation H₁-receptor Antagonist (Antihistamine)
Common Use Management of severe allergic and inflammatory conditions
Origin Synthetic

1. Dextrosone: Definition, Class, and Composition

Dextrosone is a synthetic, prescription-only fixed-dose combination product, typically provided as an oral tablet, which merges the actions of a potent steroid and an antihistamine. Its unique formulation features two distinct active pharmaceutical ingredients: Betamethasone Dipropionate and Dexchlorpheniramine. Betamethasone Dipropionate is recognized as a highly effective Glucocorticoid (corticosteroid), with its dipropionate ester enhancing its duration and potency. Glucocorticoids are widely used for their anti-inflammatory and immunosuppressive properties. Dextrosone is specifically differentiated as a dual-therapy oral tablet intended for adult use, offering a convenient alternative to separate single-agent treatments.


2. What is the General Purpose of Dextrosone?

The general therapeutic purpose of Dextrosone is the comprehensive management of conditions involving both significant inflammation and allergic hypersensitivity. The combination is structured to allow the Glucocorticoid component to provide powerful anti-inflammatory action, while the Antihistamine component offers immediate anti-allergic relief by blocking the effects of histamine. Dual therapy offers greater efficacy than monotherapy in complex allergy scenarios. The primary role of first-generation H₁-antagonists is to relieve acute allergy symptoms by blocking the receptors that histamine activates. This synergistic approach is clinically recognized for its ability to stabilize patients during acute inflammatory and allergic episodes.

Regulatory References

  1. The National Institutes of Health
  2. NIH: Glucocorticoids

What side effects are possible with Dextrosone?

Dextrosone: Possible Side Effects and Safety Information

Adverse reactions associated with Dextrosone, a combination of a glucocorticoid and a first-generation antihistamine, are documented in official regulatory sources according to the known safety profiles of both active components.

Officially classified side effects related to the antihistamine component are primarily drowsiness and sedation, which are often categorized as common or very common. Other commonly documented effects include dry mouth, dizziness, and disturbed coordination, all grouped under Nervous System and Gastrointestinal Disorders.


Serious Adverse Reactions and Systemic Safety

The safety profile includes potential for serious adverse reactions, predominantly linked to the corticosteroid component. These are documented to affect several System-Organ Classes, including Endocrine, Ocular, and Musculoskeletal Systems. Significant risks explicitly noted in regulatory documents, particularly with prolonged use, include:

  • Adrenal Suppression (inhibition of the HPA axis).
  • Development of Cataracts or Glaucoma.
  • Potential for Peptic Ulcer with subsequent hemorrhage or perforation.

Population and Contextual Safety Notes

The official labeling includes specific safety considerations for patient populations. Older adults are noted to have increased sensitivity to the central nervous system (CNS) and anticholinergic effects of the antihistamine, such as dizziness and sedation. For children, prolonged use requires careful monitoring due to the risk of growth retardation and developmental changes. Furthermore, the medication's use is officially restricted in patients with Systemic Fungal Infections, Narrow-Angle Glaucoma, or conditions causing Urinary Retention, based on the properties of the active ingredients.

These classifications establish that the most frequent effects are neurological, while the clinically significant, duration-related risks involve systemic functions, defining the official safety structure of the medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents state that clinical manifestations of Dextrosone overdose are predominantly attributable to the Dexchlorpheniramine component. Overdose may present with serious central nervous system (CNS) effects, including sedation, paradoxical excitation, toxic psychosis, convulsions (seizures), and dystonic reactions. Other documented manifestations include apnea and severe anticholinergic effects.


Life-threatening outcomes cited in the labeling include cardiovascular collapse and cardiac arrhythmias. Due to the potential for these severe events, official labeling mandates that individuals seek medical attention immediately at the first sign of any adverse reaction related to overdose and advises consultation with national poisons centers.


Overdose management consists of symptomatic and supportive measures, as no specific antidote is designated. Required management protocols include the vigorous treatment of complications such as hypotension and arrhythmias, along with continuous monitoring of cardiac, respiratory, renal, and hepatic functions. The Betamethasone component is described as unlikely to require specific treatment in acute overdose. Furthermore, children and the elderly are noted as being more likely to experience the neurological effects of excitation and anticholinergic symptoms.

Therapeutic Uses of Dextrosone

Dextrosone is commonly used for conditions marked by both significant inflammation and heightened allergic reactions that cause patient discomfort. The medication is applied in treating difficult cases of allergic presentations.

This combination therapy is relevant for easing symptoms that interfere with daily functioning, commonly seen in conditions like severe allergic rhinitis (seasonal and perennial), ocular allergies, and complex dermatologic manifestations such as hives (urticaria) and intense itching (pruritus). This approach provides supportive symptomatic relief and helps maintain a sense of stability when symptoms are more noticeable.

“The use of Dextrosone supports the patient during difficult episodes by easing distress related to both inflammation and allergic symptoms.”

By helping manage symptom clusters that may become intense or disruptive—such as repeated sneezing, profuse runny nose, and significant nasal obstruction caused by tissue swelling—this support may assist in supporting routine function and contributes to improved day-to-day comfort during periods of heightened symptoms.


Quick Fact: Relief for Symptomatic Burden

Domain Focus of Relief
Allergy Symptoms of heightened physiological activity (e.g., sneezing, itching, runny nose)
Inflammation Symptoms related to inflammatory or irritative states (e.g., tissue swelling, congestion, redness)
Use Context Conditions involving episodic or fluctuating manifestations

Regulatory References

  1. Philippines FDA Verification Portal

Eligibility and Restrictions for Use

Dextrosone, which is a form of dextrose (glucose), is used to provide fluid replenishment and calories, often when a patient cannot consume sufficient liquids orally. The use of Dextrosone is determined by a healthcare professional based on the specific formulation and the patient's medical condition.


Who Can Use Dextrosone?

  • Patients with hypoglycemia (low blood sugar), particularly in acute, symptomatic episodes.
  • Individuals requiring fluid and calorie replacement, such as those needing parenteral nutrition.
  • The use is approved across adult and pediatric patients, though dosing is carefully adjusted for neonates and infants.

Who Should Not Use Dextrosone? (Contraindications)

Administration of Dextrosone is contraindicated in patients with certain pre-existing conditions. These include:

  • A known hypersensitivity or allergy to dextrose or corn products (as dextrose is often corn-derived).
  • Clinically significant hyperglycemia (high blood sugar), as this medication can worsen the condition.
  • Severe dehydration, as hypertonic solutions can worsen the patient's hyperosmolar state.
  • Certain severe brain conditions, such as intracranial or intraspinal hemorrhage.

Caution is also advised for patients with existing fluid and electrolyte imbalances, diabetes mellitus, renal impairment, and during pregnancy or breastfeeding. A physician must weigh the benefits against the risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Dextrosone (Betamethasone Dipropionate/Dexchlorpheniramine) based on government regulatory information.


Contraindicated and Exposure-Altering Combinations

Monoamine Oxidase (MAO) inhibitors are formally contraindicated for co-administration, as they prolong and intensify the effects of the Dexchlorpheniramine component.

Exposure to the Betamethasone component is affected by contrasting metabolic interactions. Co-administration with enzyme-inducing agents such as Phenobarbital, Phenytoin, Rifampicin, and Ephedrine may enhance Betamethasone metabolism, potentially reducing its overall effect. Conversely, Estrogen may reduce Betamethasone clearance, requiring observation for signs of excessive corticosteroid effects.


Pharmacodynamic Interactions

Several combinations result in additive effects. The sedative effects of Dexchlorpheniramine are potentiated by co-administration with Alcohol and other Central Nervous System (CNS) Depressants, including Tricyclic Antidepressants and Barbiturates. The combined use of Betamethasone with Alcohol or Non-corticosteroid Anti-inflammatory Drugs increases the risk and severity of gastrointestinal ulceration.

Furthermore, Betamethasone enhances the risk of hypokalemia when combined with Potassium-depleting Diuretics or Amphotericin B. This risk may subsequently enhance the possibility of arrhythmias or digitalis toxicity when used concurrently with Cardiac Glycosides. Additionally, the action of Oral Anticoagulants may be inhibited by the Dexchlorpheniramine component.

Mechanism of Action

How Dextrosone Works

Dextrosone engages two distinct biological mechanisms that modulate specific signaling pathways. The dual mechanism acts upon both immediate chemical mediators and underlying cellular processes of inflammation.


Genomic Reprogramming of the Immune Response

The glucocorticoid component, Betamethasone Dipropionate, exerts its action via genomic regulation, acting as an agonist on the intracellular Glucocorticoid Receptor ( GR). This activated complex enters the cell nucleus to modulate gene expression, suppressing pro-inflammatory transcription factors ( NF-kappa B) and enhancing the production of anti-inflammatory proteins, such as Annexin-1. This mechanism modifies early molecular steps, leading to the inhibition of the Arachidonic Acid Cascade and the subsequent reduction in synthesizing key inflammatory lipids like prostaglandins and leukotrienes. This genomic effect results in an alteration of gene expression patterns within the immune system.


Acute Receptor Blockade of Histamine Signaling

The antihistamine component, Dexchlorpheniramine, initiates receptor blockade quickly by competitively blocking the Histamine H1-Receptor on cell surfaces. By physically occupying this receptor, the drug prevents histamine from binding and initiating the G q/11 signaling sequence. This targeted blockade of the acute mediator reduces the effect of vascular mediator activity, primarily resulting in a reduction of histamine-driven increases in capillary permeability and the prevention of the stimulation of sensory nerves.


Orthogonal Mechanistic Synergy

The two components are mechanistically orthogonal, meaning they affect different pathways at different times. Dexchlorpheniramine initiates receptor blockade quickly, and Betamethasone Dipropionate provides sustained genomic pathway modulation. This combined approach engages mechanisms that modulate both the acute chemical mediator pathway and the sustained cellular inflammatory pathway.

Dosage and Administration Information

How Dextrosone is Used

Dextrosone, a fixed-dose combination product containing Betamethasone and Dexchlorpheniramine, is used exclusively through oral administration via either a tablet or a liquid/syrup formulation. Clinical application follows specific dosage, frequency, and duration patterns.


Standard Labeled Dosing

The medicine is administered using a divided daily regimen to maintain systemic levels. The table below outlines the usual frequency and dosing for adult patients and children aged 12 and older:

Population Dosage Form Usual Dose Frequency
Adults and Children ge 12 Tablet (0.25 mg/2 mg) 1 to 2 tablets Four times daily (QID)
Adults and Children ge 12 Liquid/Syrup 5 mL to 10 mL Four times daily (QID)

The maximum recommended daily dose is 8 tablets or 40 mL of the liquid. Dosage should be individualized and gradually reduced by the prescriber as a response is achieved.


Administration Conditions and Duration

The official instruction is to take Dextrosone after meals and at bedtime. Treatment is intended for short-term use only, and it is generally recommended not to exceed 5 days per course. If using the liquid form, the container must be shaken well before use. If a dose is missed, a patient should not take a double dose to compensate. Due to the antihistamine component, the medication must be discontinued approximately 48 hours prior to skin testing procedures to prevent interference with test results.

Recent Clinical Evidence

Research evidence / Overview of studies

Research has explored the drug’s biological activity. Furthermore, studies have been conducted to evaluate whether the studied use was associated with specific changes in patient metrics. The agent has been the subject of research in the context of pain management and in specific nutritional/fluid support roles.


Study 1: Acute Use (Analgesia)

A randomized, controlled trial examined the agent in chronic low back pain with leg pain, focusing on a single epidural injection. The trial compared the agent to a control (saline) and investigated whether the agent was associated with greater changes in pain scores at early time points (e.g., 15 minutes, 2 hours, and 4 hours) post-injection, as well as at 48 hours. The trial included evaluation of expected and unexpected occurrences in the studied population.


Study 2: Long-term and Musculoskeletal Use

Studies investigating the agent in the treatment of various musculoskeletal pain conditions (e.g., knee osteoarthritis, plantar fasciitis, shoulder pain) have focused on its potential role as a subcutaneous injection, often referred to as dextrose prolotherapy. This long-term data also included an examination of occurrences across various sub-groups. Comparative analyses were conducted against older treatment methods or saline to determine whether differences in outcomes, such as pain-related functioning, were observed over medium- to long-term follow-up periods. Evidence suggests that for some conditions, the benefit is either very uncertain or may be minimal, indicating that the technique remains under development and requires further investigation.

Key Studies & References Systematic Review of Dextrose Solutions for Pain Management: Mechanisms and Clinical Applications

Frequently Asked Questions (FAQ)

Common questions about Dextrosone (FAQ)


Q: Why is Dextrosone prescribed for so many different conditions?

A: The official documents describe Dextrosone as a combination of two active ingredients: a glucocorticoid (a potent anti-inflammatory agent) and an antihistamine. Glucocorticoids are known to modulate the immune system and are used to manage a wide spectrum of inflammatory and immune-related conditions. This dual action allows the medicine to be used for various severe allergic and inflammatory states.


Q: What is Dextrosone used for other than its main indication?

A: The officially approved uses for Dextrosone, as stated in the official product information, are focused on the comprehensive relief of severe allergic and inflammatory conditions where systemic (body-wide) treatment is deemed necessary. The scope of use is restricted to the specific indications defined by regulatory bodies.


Q: How quickly does Dextrosone start working after taking it?

A: The effect of Dextrosone is dual: the antihistamine component is described as acting relatively quickly by immediately blocking receptors. The corticosteroid component, however, works by modulating gene expression, which results in a more sustained effect that takes longer to develop fully.


Q: What is the typical duration of Dextrosone's effects in the body?

A: The duration of the medicine's effect is influenced by the two different ingredients. The corticosteroid component is characterized as being long-acting, meaning its effects on the body's inflammatory pathways are sustained. The overall duration is therefore dependent on the time it takes for both the long-acting steroid and the antihistamine to be metabolized.


Q: Is it normal to feel tired or weak when I start taking Dextrosone?

A: Official safety information states that drowsiness and sedation are common side effects linked to the antihistamine component. Additionally, the label documents that muscle weakness is a possible systemic effect associated with the corticosteroid component. Should these effects be disruptive or concerning, patients may wish to communicate them to their healthcare provider.


Q: Can Dextrosone cause mood changes or emotional side effects?

A: Yes, the official labels describe that the corticosteroid component may be associated with effects on the central nervous system. These documented effects can include behavioral or mood changes, such as depression, nervousness, or euphoria.


Q: Are there any specific supplements that are known to interact with Dextrosone?

A: Regulatory documents primarily detail known interactions with prescription medications. Specific information on every herbal or dietary supplement interaction is generally not addressed in the official drug label. Because official information does not cover all possible combinations, patients may wish to discuss any supplements they take with their prescriber.


Q: Is Dextrosone known to affect sleep or cause insomnia?

A: Official documents indicate that the corticosteroid component of the medicine is associated with the potential for sleep disturbances or insomnia in some individuals. This is distinct from the drowsiness caused by the antihistamine component.


Q: Is Dextrosone a habit-forming drug?

A: According to regulatory classifications, Dextrosone is not officially listed as a controlled substance. The medicine is not described in official documents as having potential for habit-forming behavior or physical dependence.


Q: Can Dextrosone impact blood sugar levels?

A: Yes, the official label notes that the corticosteroid component is associated with effects on the endocrine system. This includes the potential to increase blood glucose levels, which is a condition known as hyperglycemia. Specific warnings are included in the labeling regarding use by patients with diabetes mellitus.


Q: Does Dextrosone cause weight gain?

A: Yes, weight gain is a documented side effect listed in official documents. This effect is associated with the corticosteroid component of the medicine, particularly when it is used for longer periods.


Q: Is Dextrosone available as a generic medicine?

A: Information regarding the availability of a generic version of this combination product is generally published in national drug compendia. The generic status of any medicine is recorded in the public regulatory listings of national agencies.


Q: What is the typical time frame for the full effect of Dextrosone to be noticed?

A: The full therapeutic effect is reached over time, as the primary anti-inflammatory and immunosuppressive effects are due to the corticosteroid component. Because this component works by modulating genes, achieving the full effect generally takes longer than the immediate relief provided by the antihistamine component.


Q: What should I do if I experience a mild side effect from Dextrosone?

A: Official drug labeling and patient information do not provide personalized instruction or guidance on managing side effects. The regulatory guidance and patient information suggest communicating all side effects, whether mild or severe, to a healthcare provider.


Q: What happens if I accidentally take too much Dextrosone?

A: The official label provides a description of the possible effects of overdosage. These effects may include an increase in common side effects such as drowsiness and gastrointestinal distress, as well as other more serious effects related to the active components.


Q: Can Dextrosone be used by vegetarians or vegans?

A: Whether the medicine is suitable for specific dietary needs, such as vegetarian or vegan, depends on its non-active ingredients, or excipients. The full regulatory information lists all of these ingredients, which can be checked against specific dietary requirements.


Q: Is Dextrosone safe for people who have kidney issues?

A: Official regulatory documents advise that the medicine should be used with caution in patients who have pre-existing renal impairment (kidney issues). This is because kidney function can impact how the drug is cleared from the body. The determination of use requires a healthcare provider to evaluate the individual risk versus benefit.


Q: Can Dextrosone be used by people who are pregnant or planning to be pregnant?

A: The use of Dextrosone during pregnancy or breastfeeding is a matter of official caution in the labeling. The labeling indicates that a healthcare provider must carefully weigh the potential benefits against the risks to the fetus or infant before prescribing the medication.


Q: What does the official research evidence say about Dextrosone's use in children?

A: The official label includes specific warnings regarding pediatric use. This information notes the potential for the corticosteroid component to cause growth retardation in children when administered for a prolonged period. For this reason, use in the pediatric population often includes recommendations for careful monitoring.


Q: Why do official documents mention 'risk vs benefit' when talking about Dextrosone?

A: The official mention of balancing risk vs. benefit is due to the presence of a potent glucocorticoid (corticosteroid) component. While this component offers therapeutic benefits, it is also officially associated with a range of serious systemic risks, such as adrenal gland suppression, which necessitate careful evaluation in the clinical setting.


Q: Is Dextrosone suitable for people with high blood pressure?

A: Regulatory documents advise that official caution is necessary for patients with pre-existing hypertension (high blood pressure). This warning is based on the risk that the corticosteroid component may potentially worsen the condition or require closer medical monitoring.


Q: What is the risk of an allergic reaction to Dextrosone?

A: A known allergy or hypersensitivity to the active ingredients or any component of the drug is listed as a contraindication (should not be used). Official safety labels describe signs of a serious allergic reaction, such as rash or swelling, as conditions that indicate a need for prompt medical consideration.


Q: Does Dextrosone have a black box warning described in official sources?

A: Whether Dextrosone carries a Black Box Warning (BBW) is a specific, factual claim that can be verified in the public record. This warning is the most serious advisory placed by the FDA on its official prescribing information.


Q: What is the purpose of the initial testing that doctors perform before prescribing Dextrosone?

A: Official guidance may recommend initial testing to check for certain pre-existing conditions that are listed as contraindications (reasons the drug should not be used). This is primarily to screen for conditions, such as systemic fungal infections, that would make the use of a corticosteroid unsafe.


Q: Does Dextrosone affect fertility in men or women?

A: Official labels document that the use of corticosteroids can affect the hypothalamic-pituitary-adrenal (HPA) axis. For women, this effect may be associated with menstrual irregularities. Information relating to fertility is part of the drug’s overall safety profile.


Q: Are there special warnings for people with diabetes using Dextrosone?

A: Regulatory documents contain specific warnings for individuals with diabetes mellitus. Due to the risk of elevated blood sugar, the warning indicates that careful monitoring of blood glucose levels may be required while taking the medicine.


Q: Do any official studies discuss the quality of life changes associated with Dextrosone?

A: Official research evidence often examines patient-reported outcomes which capture the overall effect of the medicine on a person's life. While the specific phrase 'quality of life' may not be universally used, studies do investigate changes in metrics like pain-related functioning and well-being.


Q: Is Dextrosone safe for older adults (seniors)?

A: Official safety notes for older adults indicate they may have increased sensitivity to certain effects of the antihistamine component. This includes a heightened risk of dizziness and sedation. The prescribing information includes notes on caution and monitoring for these potential effects when administered to older adults.


Q: What kind of monitoring is typically required while taking Dextrosone?

A: When used for an extended period, the official label indicates that specific medical monitoring may be required. This can include checks for adrenal function, monitoring of blood pressure and glucose levels, and eye examinations to check for conditions like cataracts.


Q: Can Dextrosone interact with herbal remedies?

A: Official regulatory documents focus on documenting interactions with known prescription medications. Information regarding all herbal remedies or dietary supplements is generally not addressed in the official drug label.


Q: Are there specific official guidelines for taking Dextrosone around the time of surgery?

A: Official warnings note that consideration may be given to supplemental corticosteroid dosing during periods of physical stress, such as major trauma or surgery. This is due to the risk that the corticosteroid component may have suppressed the body's natural adrenal function.


Q: What if Dextrosone does not seem to be working for my condition?

A: Official guidance suggests that patients should communicate with the prescribing physician if the expected benefit from the medicine is not being achieved. This communication is essential as the physician may need to assess the condition or adjust the individualized dosing regimen.


Q: What are the official sources of information about Dextrosone's safety?

A: The official safety and effectiveness information for Dextrosone is derived from comprehensive reviews of data. This information is published and maintained by governmental regulatory agencies globally, such as the FDA (in the US) and the EMA (in Europe).

How should Dextrosone be stored and disposed of?

How to Store and Dispose of Dextrosone Tablets

The storage of Dextrosone (Betamethasone/Dexchlorpheniramine) oral tablets must adhere to specific regulatory requirements to maintain product stability and quality. The medication must be kept in a cool, dry place with the temperature not exceeding 30°C.

Storage Component Requirement
Temperature Do not store above 30°C (86°F).
Environment Must be kept dry and protected from light.
Container Store in a tight container to maintain integrity.

For safety, the tablets must be stored out of the reach of children and kept in a secure location. The official disposal instructions require that unused or expired tablets and the container be discarded in accordance with local waste regulations; there are no special requirements for controlled-waste disposal for the finished product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dextrosone found in:

A-Z Index: